Blue Mountains Cohort Study: Incidence Of Eye Disease, Hearing Loss And Other Health Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$813,250.00
Summary
The proposed study aims to determine the cumulative 10-year incidence and progression of the major eye diseases that threaten vision in older Australians, including age-related maculopathy, cataract, glaucoma and diabetic retinopathy. The cumulative 5-year incidence of age-related hearing loss and prevalence of loss of smell will also be determined. The study will assess risk factors and associations with these diseases, using information collected at the baseline, 5-year and 10-year examination ....The proposed study aims to determine the cumulative 10-year incidence and progression of the major eye diseases that threaten vision in older Australians, including age-related maculopathy, cataract, glaucoma and diabetic retinopathy. The cumulative 5-year incidence of age-related hearing loss and prevalence of loss of smell will also be determined. The study will assess risk factors and associations with these diseases, using information collected at the baseline, 5-year and 10-year examinations on medical history, ocular factors, vascular disease, smoking, diet, plus environmental and blood factors. The study aims to assess the impact of these sensory impairments on measures of dependence, quality of life, general health, age-related cognitive impairment, depression and on mortality. The study will be conducted in Katoomba on the cohort of residents from two postcode areas who originally attended the Blue Mountains Eye Study during the period 1992-4. Examinations will commence by May, 2002 and be completed by April, 2004. We hope to examine 2,032 of the original cohort of 3,654 people. This project will build on the data already collected by the Blue Mountains Eye Study, one of the most successful community surveys conducted in Australia. The 10-year follow-up period will provide increased statistical power and precision to assess the role of possible risk factors for eye disease already identified by the earlier baseline and 5-year studies of this population. The hearing component of the study will provide the first longitudinal data on hearing loss from a large older Australian population.Read moreRead less
Genes And Environment In Late AMD: Pooling A State And Population Resource
Funder
National Health and Medical Research Council
Funding Amount
$701,642.00
Summary
This study will pool cases from the West Australian Macular Degeneration database with the Blue Mountains Eye Study (NSW), to investigate the interplay of genes and environmental factors on risk of age-related macular degeneration (AMD), in particular the late, vision threatening stage. It will provide insights into the underlying causes of AMD, and could allow us to target people with AMD susceptibility genes for preventive approaches, which could reduce the burden of this disease.
Genes And Environment In The Risk Of Early Age-Related Macular Degeneration: A Population-based Case-Control Study
Funder
National Health and Medical Research Council
Funding Amount
$949,588.00
Summary
This study will pool data from three well-conducted population-based cohorts of older persons to gain a large sample size in order to investigate the interplay of genes and environmental factors on the risk of age-related macular degeneration (AMD). The study will give insights into AMD pathogenesis, and enable potential targeting of people with AMD susceptibility genes for preventive approaches. These could ultimately reduce the burden of this blinding condition.
Sensory Impairment: Causes, Impacts And Interventions
Funder
National Health and Medical Research Council
Funding Amount
$2,233,350.00
Summary
The team will bring focused expertise to building Australian research capacity in the relatively underdeveloped priority area of sensory impairment. The focused, practical program of sensory impairment population health research includes the themes of epidemiology of sensory impairment (particularly vision and hearing); vascular, genetic, nutritional inter-relationships with sensory impairment and associated diseases, and impacts of sensory impairment on independent living.
Managing Return-to-play Decisions Following Mild Traumatic Brain Injury (mTBI): A Cohort Study
Funder
National Health and Medical Research Council
Funding Amount
$63,350.00
Summary
Contact sports, such as rugby, carry a high risk of mild traumatic head injury (mTBI) and such injuries have the potential for adverse long-term sequelae. There are conflicting guidelines about when a player should return to play. The study aims to estimate the incidence of rugby-related mTBI, assess the role of risk and protective factors, and develop recommendations for managing return-to-play decisions following mTBI in community level rugby players within the Sydney metropolitan area.
A Population-based Study Of Progression And Risk Factors For Age-related Maculopathy
Funder
National Health and Medical Research Council
Funding Amount
$776,022.00
Summary
Age-related macular degeneration (AMD) is a progressive disease, commencing with the less severe age-related maculopathy (ARM), that ultimately can lead to the loss of fine central vision and personal independence. People with advanced AMD generally retain some mobility if their peripheral vision is maintained, but they are unable to perform tasks such as reading, hobbies or recognising people's faces. Unfortunately, the available treatment for AMD, macular laser photocoagulation, benefits only ....Age-related macular degeneration (AMD) is a progressive disease, commencing with the less severe age-related maculopathy (ARM), that ultimately can lead to the loss of fine central vision and personal independence. People with advanced AMD generally retain some mobility if their peripheral vision is maintained, but they are unable to perform tasks such as reading, hobbies or recognising people's faces. Unfortunately, the available treatment for AMD, macular laser photocoagulation, benefits only a minority of people with this disease. Until safe and effective treatments for AMD can be developed, identification of major risk factors for the development and progression of AMD is essential to determine if interventions aimed at primary prevention can be initiated. This project will expand on the initial findings of the Visual Impairment Project (VIP), a population-based study of age-related eye disease in a cohort of more than 5000 Victorians aged 40 years and older. Data from the VIP have shown that AMD is the most important ophthalmologic public health problem, particularly since AMD is the major cause of vision impairment in Australia and has the least available treatment options. This study will follow individuals who were identified in the VIP with ARM-AMD to determine the natural history and risk factors associated with the longer term progression of AMD. Particular emphasis will be on determining the role of cardiovascular disease risk factors in AMD progression.Read moreRead less